Global POC/Point-of-Care Clinical Chemistry & Immunodiagnostic Testing Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: DiaSorin, Eiken, Bio-Rad - Research and Markets

Thursday, March 31, 2016

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "2016-2020 POC/Point-of-Care Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering.

This new report provides a comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.

Contains 500 pages and 129 tables

Companies Mentioned:

  • Abbott Laboratories
  • AdnaGen/Alere
  • Agilent Technologies
  • Bayer Healthcare
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/hk9lnd/20162020.

TOP